CHRISTINA NGUYEN: Open Payments
NPI 1891227807 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,299 in 87 payments from 20 companies in 2025. Trend: 2023 $263 · 2024 $2,386 · 2025 $2,299
Food & beverage: $2,299
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 10 | $455 |
| Neurocrine BioSciences, Inc. | 13 | $394 |
| AstraZeneca Pharmaceuticals LP | 9 | $338 |
| ABBVIE INC. | 13 | $282 |
| Exact Sciences Corporation | 7 | $171 |
| SHIELD THERAPEUTICS INC | 7 | $120 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $94 |
| Novo Nordisk Inc | 4 | $72 |
| Lilly USA, LLC | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
Products named: VOQUEZNA, INGREZZA, The Cologuard Plus Collection Kit, VRAYLAR, BREZTRI, ACCRUFER, QULIPTA, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
